AIMS Award from Atomwise
Some big news about tiny molecules: cc-TDI has recently been awarded an AIMS Award from Atomwise to create a molecularly-designed new drug for EWSR1 fusion
Some big news about tiny molecules: cc-TDI has recently been awarded an AIMS Award from Atomwise to create a molecularly-designed new drug for EWSR1 fusion
Some big news about tiny molecules: cc-TDI has recently been awarded an AIMS Award from Atomwise to create a molecularly-designed new drug for EWSR1 fusion
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2023 – Children’s Cancer Therapy Development Institute